HBSAG LOSS WITH TENOFOVIR DISOPROXIL FUMARATE PLUS PEGINTERFERON ALFA-2A IN CHRONIC HEPATITIS B: LONG-TERM RESULTS OF A GLOBAL RANDOMIZED CONTROLLED TRIAL

被引：0
|
作者：
Ahn, S. -H. [1 ]
Marcellin, P. [2 ]
Ma, X. [3 ]
Caruntu, F. [4 ]
Tak, W. Y. [5 ]
Elkhashab, M. [6 ]
Chuang, W. -L. [7 ]
Tabak, F. [8 ]
Mehta, R. [9 ]
Petersen, J. [10 ]
Corsa, A. [11 ]
Martins, E. B. [11 ]
Yee, L. J. [11 ]
Dinh, P. [11 ]
Subramanian, G. Mani [11 ]
Buti, M. [12 ]
Gaeta, G. [13 ]
Papatheodoridis, G. [14 ]
Flisiak, R. [15 ]
Chan, H. L. Y. [16 ]
机构：
[1] Yonsei Univ, Coll Med, Seoul, South Korea
[2] Univ Paris Diderot, Hop Beaujon, Clichy, France
[3] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[4] Natl Inst Infect Dis Prof Dr Matei Bals, Bucharest, Romania
[5] Kyungpook Natl Univ, Sch Med, Daegu, South Korea
[6] Toronto Liver Ctr, Toronto, ON, Canada
[7] Kaohsiung Med Univ, Chung Ho Mem Hosp, Kaohsiung, Taiwan
[8] Istanbul Univ Cerrahpasa, Fac Med, Istanbul, Turkey
[9] Liver Clin, Surat, India
[10] Univ Hamburg, Hamburg, Germany
[11] Gilead Sci, Foster City, CA USA
[12] Hosp Univ Vall dHebron, Barcelona, Spain
[13] Univ Naples 2, Naples, Italy
[14] Univ Athens, Sch Med, Athens, Greece
[15] Med Univ Bialystok, Bialystok, Poland
[16] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)00924-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-256
引用
收藏
页码：S524 / S525
页数：2
相关论文
共 50 条
  • [21] Long-term effects of peginterferon alfa-2a therapy in Japanese patients with chronic hepatitis B virus infection
    Keiichi Masaki
    Fumitaka Suzuki
    Tasuku Hara
    Yusuke Kawamura
    Hitomi Sezaki
    Tetsuya Hosaka
    Norio Akuta
    Masahiro Kobayashi
    Satoshi Saitoh
    Yoshiyuki Suzuki
    Yasuji Arase
    Kenji Ikeda
    Mariko Kobayashi
    Hiromitsu Kumada
    Virology Journal, 12
  • [22] Long-term effects of peginterferon alfa-2a therapy in Japanese patients with chronic hepatitis B virus infection
    Masaki, Keiichi
    Suzuki, Fumitaka
    Hara, Tasuku
    Kawamura, Yusuke
    Sezaki, Hitomi
    Hosaka, Tetsuya
    Akuta, Norio
    Kobayashi, Masahiro
    Saitoh, Satoshi
    Suzuki, Yoshiyuki
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    VIROLOGY JOURNAL, 2015, 12
  • [23] Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results
    Xieer Liang
    Zhiliang Gao
    Qing Xie
    Jiming Zhang
    Jifang Sheng
    Jun Cheng
    Chengwei Chen
    Qing Mao
    Wei Zhao
    Hong Ren
    Deming Tan
    Junqi Niu
    Shijun Chen
    Chen Pan
    Hong Tang
    Hao Wang
    Yimin Mao
    Jidong Jia
    Qin Ning
    Min Xu
    Shanming Wu
    Jun Li
    Xinxin Zhang
    Wenyan Zhang
    Cui Xiong
    Jinlin Hou
    Hepatology International, 2019, 13 : 260 - 269
  • [24] Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results
    Liang, Xieer
    Gao, Zhiliang
    Xie, Qing
    Zhang, Jiming
    Sheng, Jifang
    Cheng, Jun
    Chen, Chengwei
    Mao, Qing
    Zhao, Wei
    Ren, Hong
    Tan, Deming
    Niu, Junqi
    Chen, Shijun
    Pan, Chen
    Tang, Hong
    Wang, Hao
    Mao, Yimin
    Jia, Jidong
    Ning, Qin
    Xu, Min
    Wu, Shanming
    Li, Jun
    Zhang, Xinxin
    Zhang, Wenyan
    Xiong, Cui
    Hou, Jinlin
    HEPATOLOGY INTERNATIONAL, 2019, 13 (03) : 260 - 269
  • [25] A Randomized Placebo-Controlled Trial of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients with Minimally Elevated Aminotransferase
    Hsu, Yao-Chun
    Chen, Chi-Yi
    Wu, Chun-Ying
    Chang, I-Wei
    Lee, Teng-Yu
    Chang, Chi-Yang
    Bair, Ming-Jong
    Chen, Jyh-Jou
    Wu, Ming-Shiang
    Chen, Chieh-Chang
    Tseng, Cheng-Hao
    Ku, Wen-Hui
    Mou, Lien-Juei
    Lin, Jaw-Town
    HEPATOLOGY, 2018, 68 : 162A - 162A
  • [26] Clinical Efficacy and Safety of Long-Term Treatment of Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate for Chronic Hepatitis B in Vietnam
    Nguyen, Thao Huynh Phuong
    Bui, Quynh Thi Huong
    Vo, Thong Duy
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2024, 15 (10)
  • [27] Pharmacodynamics of peginterferon alfa-2a and peginterferon alfa-2b in interferon-naive patients with chronic hepatitis C: a randomized, controlled study
    Bruno, R.
    Sacchi, P.
    Scagnolari, C.
    Torriani, F.
    Maiocchi, L.
    Patruno, S.
    Bellomi, F.
    Filice, G.
    Antonelli, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (03) : 369 - 376
  • [28] An observational study on long-term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate
    Lim, Tae Seop
    Lee, Jae Seung
    Kim, Beom Kyung
    Lee, Hye Won
    Jeon, Mi Young
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (03) : 316 - 322
  • [29] Long-term use of tenofovir disoproxil fumarate increases fracture risk in elderly patients with chronic hepatitis B
    Yip, Terry Cheuk-Fung
    Lai, Jimmy Che-To
    Yam, Tsz-Fai
    Tse, Yee-Kit
    Hui, Vicki Wing-Ki
    Lai, Mandy Sze -Man
    Chan, Henry Lik-Yuen
    Wong, Vincent Wai-Sun
    Wong, Grace Lai-Hung
    JOURNAL OF HEPATOLOGY, 2024, 80 (04) : 553 - 563
  • [30] Does long-term use of tenofovir disoproxil fumarate affect fracture risk in patients with chronic hepatitis B?
    Zhang, Haitao
    Huang, Jin
    Zhu, Wenhao
    Feng, Wenjun
    Zeng, Yirong
    JOURNAL OF HEPATOLOGY, 2024, 81 (04) : e199 - e200
12345